The China Kidney Dialysis Machines market is witnessing robust growth, driven by rising incidences of chronic kidney disease and rapid expansion of healthcare infrastructure. The market size was valued at USD 2,150 Million in 2025 and is expected to reach USD 4,900 Million by 2035, registering a CAGR of 7.8% from 2024 to 2035.
The economic impact of tariffs on "China Kidney Dialysis Machines".
China Kidney Dialysis Machines Market Growth Drivers
Increasing Prevalence of Chronic Kidney Disease: According to Fresenius Medical Care, the growing incidence of diabetes and hypertension in China has significantly contributed to a surge in patients requiring dialysis. In 2023, over 120 million people were estimated to have chronic kidney disease, leading to greater demand for dialysis machines. The government’s push for early diagnosis and patient education is also playing a vital role in market expansion.
Expansion of Health Insurance Coverage: Baxter International has noted that China’s aggressive expansion of health insurance coverage, particularly through the Healthy China 2030 initiative, has improved access to end-stage renal disease (ESRD) treatments. More hospitals and dialysis centers are equipped with advanced dialysis machines, encouraging both domestic and foreign manufacturers to expand their operations and invest in localized research and development.
China Kidney Dialysis Machines Market Trends
Technological Advancements and Smart Dialysis Machines: Companies such as B. Braun are integrating advanced digital technologies such as IoT and AI into dialysis machines. These newer models enable real-time patient monitoring, automatic adjustment of dialysis parameters, and remote maintenance, offering improved user experience for both patients and healthcare providers. This trend is driving market differentiation and product innovation.
Rise of Home Hemodialysis: With support from policy initiatives and an increased focus on patient comfort, there is a notable shift toward home-based dialysis solutions. Players like Asahi Kasei Medical are launching compact, user-friendly machines designed for home settings, reducing dependency on clinical visits. The COVID-19 pandemic further accelerated this trend, creating sustained demand for decentralized treatment options.
China Kidney Dialysis Machines Market Opportunity
Emergence of Local Manufacturers: The rise of local Chinese medical device companies, such as WEGO Group, presents significant growth opportunities. These firms are leveraging lower production costs and local market knowledge to offer affordable, high-quality dialysis machines that cater to mid- and small-scale healthcare providers.
Government-Led Initiatives for Rural Healthcare: The Chinese government’s focus on healthcare infrastructure development in rural regions provides opportunities for companies like Mindray to introduce cost-effective kidney dialysis machines, aiming to address the disparities in healthcare access across urban and rural populations.
China Kidney Dialysis Machines Market Revenue (USD Million), 2020-2035
The chart illustrates steady growth in China’s Kidney Dialysis Machines market from 2020 (USD 1,380 Million) to a projected USD 4,900 Million by 2035. The growth trajectory highlights robust investments, ongoing healthcare reforms, and technological advancements. Revenue growth accelerates notably post-2024, driven by increased adoption in both urban and rural areas and supportive government initiatives. The sharpest increase is expected in the decade following 2025, reflecting the cumulative effect of policy support, insurance expansion, and greater market penetration by domestic suppliers. By the end of 2035, the market is anticipated to be more than three times its 2020 valuation.
China Kidney Dialysis Machines Market by Regions Share (%), 2025
The pie chart delineates regional market shares for kidney dialysis machines in China for 2025. The East China region leads with 38%, driven by well-developed healthcare systems in provinces such as Jiangsu and Zhejiang. North China follows at 26%, buoyed by Beijing and Tianjin’s advanced medical infrastructure. South China commands 17% of the market, supported by Guangdong’s thriving medical sector. Central China holds a 12% share, with rising government investment in healthcare. Western China represents 7%, reflecting ongoing efforts to bolster medical access in less-developed areas. Regional disparities emphasize market opportunities tied to economic development and healthcare policies.
China Kidney Dialysis Machines Recent Developments (Jan-June 2024)
Fresenius Medical Care launched its latest 5008 CorDiax dialysis machine in China in March 2024. The new system incorporates advanced data analytics and cloud connectivity, enabling seamless remote monitoring and personalized treatment adjustments, enhancing outcomes for patients and improving workflow efficiency for hospitals.
In April 2024, WEGO Group signed an agreement with the Henan Provincial Government to establish a state-of-the-art kidney dialysis equipment manufacturing facility. The plant aims to increase local production capacity and reduce reliance on imported dialysis machines, aligning with national self-sufficiency goals.
Baxter Healthcare, in May 2024, introduced its AK98 next-generation hemodialysis system at major hospitals in Shanghai and Guangzhou. The launch emphasizes faster treatment cycles, water-saving technology, and integration with hospital EMR systems, helping medical centers optimize resource usage and meet rising patient demand.
Press Releases